There are 717 resources available
LBA1 - Baseline characteristics of patients from Asia enrolled in monarchE, evaluating abemaciclib in high risk early breast cancer
Presenter: In Hae Park
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
LBA3 - Early detection and localization of multiple cancers using a blood-based methylation assay (ELSA-seq)
Presenter: Qiang Gao
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
379MO - Durvalumab (D) ± tremelimumab (T) + platinum-etoposide (EP) in 1L ES-SCLC: Characterization of long-term clinical benefit and tumour mutational burden (TMB) in CASPIAN
Presenter: Jun Ho Ji
Session: Mini oral session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
380MO - A phase II trial of atezolizumab, bevacizumab, pemetrexed and carboplatin combination for metastatic EGFR-mutated NSCLC after TKI failure
Presenter: Tai Chung Lam
Session: Mini oral session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
356MO - Osimertinib adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) NSCLC (ADAURA): Central nervous system (CNS) disease recurrence
Presenter: Masahiro Tsuboi
Session: Mini oral session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
366MO - Osimertinib plus platinum/pemetrexed in newly diagnosed EGFR mutation (EGFRm)-positive advanced NSCLC: Safety run-in results from the FLAURA2 study
Presenter: Sang-We Kim
Session: Mini oral session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
381MO - Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib)
Presenter: Keunchil Park
Session: Mini oral session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
382MO - The preliminary safety result of a phase II study of osimertinib in combination with platinum + pemetrexed in patients with previously untreated EGFR-mutated advanced NSCLC (NEJ032C/LOGIK1801: OPAL)
Presenter: Ryo Morita
Session: Mini oral session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
383MO - Tepotinib in Asian patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping
Presenter: James Chih-Hsin Yang
Session: Mini oral session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
Live Q&A and live discussion
Presenter: Daniel Weng Tan
Session: Joint SITC-ESMO Immunotherapy Primer 1
Resources:
Webcast